Here’s what you need to know.
1. The company released its earnings on Aug. 3. It had a $0.27 earnings per share for the quarter, which was significantly lower than Thomson Reuters’ $0.35 EPS estimate.
2. Four research analysts gave Entellus a “buy” rating.
3. During the quarter, Entellus earned $18.73 million.
4. Revenue was also up 23.3 percent on a year-over-year basis.
More orthopedic and spinal device news:
Alphatec CFO resigns; company cuts workforce by 20% & more company updates — 5 key points
Capital Regional Orthopaedic performs 1st NUsurface procedure in NY: 4 notes
Medicare spends $1.5B on defective devices — 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
